Alisa Lask Power - 13 Dec 2023 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha as attorney-in-fact for Alisa Lask pursuant to power of attorney previously filed.
Issuer symbol
NEPH
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 16:48:32 UTC
Previous filing
14 Aug 2023
Next filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Award $0 +9,291 +24% $0.000000 48,629 13 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEPH Stock Option (right to buy) 9,617 13 Dec 2023 Common Stock 9,617 $5.22 Direct F2
holding NEPH Stock Option (right to buy) 5,568 13 Dec 2023 Common Stock 5,568 $8.57 Direct F2
holding NEPH Stock Option (right to buy) 6,850 13 Dec 2023 Common Stock 6,850 $8.06 Direct F2
holding NEPH Stock Option (right to buy) 7,062 13 Dec 2023 Common Stock 7,062 $6.82 Direct F3
holding NEPH Stock Option (right to buy) 7,080 13 Dec 2023 Common Stock 7,080 $1.07 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date.
F2 Fully exercisable.
F3 This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.
F4 This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.